Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Alternus Clean Energy Receives Nasdaq Delisting Notice; Intends to Appeal and Regain Compliance Within Timeframes Allowed
04:00pm, Friday, 20'th Sep 2024
Fort Mill, South Carolina--(Newsfile Corp. - September 20, 2024) - Alternus Clean Energy Inc. (NASDAQ: ALCE) ("Alternus", "The Company") received a Delisting Notice from the Listing Qualifications Dep
New York, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Longevity Biomedical, Inc. (“Longevity” or “Longevity Biomedical”), a biopharmaceutical company focused on advancing new technologies across thera
BioHarvest Sciences reshuffles board amid Nasdaq listing efforts
09:45am, Friday, 20'th Sep 2024
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has announced the resignation of David Ryan as a director of the company. The company highlighted that Ryan will remain a key member of its management te
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
09:00am, Friday, 20'th Sep 2024
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasda
Nasdaq to dip as Apple iPhone 16 store launch kicks off
08:31am, Friday, 20'th Sep 2024
US tech stocks are expected to open lower this Friday, with the Nasdaq 100 down 0.13% to 19,809 in pre-market trades. Apple Inc (NASDAQ:AAPL, ETR:APC), the largest of the Nasdaq constituents, is expec
NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- M3-Brigade Acquisition V Corp. (the “Company”) announced that, commencing on September 23, 2024, holders of the units sold in the Company's initial pu
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
07:01am, Friday, 20'th Sep 2024
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies f
Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
05:25pm, Thursday, 19'th Sep 2024
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company's
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:03pm, Thursday, 19'th Sep 2024
SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializa
authID Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Thursday, 19'th Sep 2024
Denver, Sept. 19, 2024 (GLOBE NEWSWIRE) -- authID Inc. (Nasdaq: AUID), a leading provider of biometric identity verification and authentication solutions, today announced the grant of non-qualifi
23andMe faces Nasdaq delisting after its entire board resigns
02:40pm, Thursday, 19'th Sep 2024
CNBC's Deidre Bosa joins 'The Exchange' to report on the latest drama in 23andMe.
23andMe faces Nasdaq delisting
12:48pm, Thursday, 19'th Sep 2024
CNBC's Deidre Bosa joins 'Money Movers' to discuss the latest updates on 23andMe's, following the exodus of several independent board members.
SRIVARU Holding Limited Secures Nasdaq Panel Approval for Continued Listing Amid Compliance Efforts
11:54am, Thursday, 19'th Sep 2024
GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) ("SRIVARU" or the "Company"), a leading innovator in the electric motorcycle market, toda
Agape ATP Corporation Regains Compliance with Nasdaq's Minimum Bid Price Rule
09:20am, Thursday, 19'th Sep 2024
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / September 19, 2024 / AGAPE ATP Corporation ("ATPC" or the Company) , is pleased to announce that it has regained compliance with the $1 minimum bid price requirem
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
08:30am, Thursday, 19'th Sep 2024
BOULDER, CO / ACCESSWIRE / September 19, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlo
